﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>patent expiration news stories on Newser</title><description>Read more patent expiration stories on Newser</description><link>http://www.newser.com/taggrid/23590/patent-expiration.html</link><copyright>2009 - Newser</copyright><language>en-us</language><generator>Newser Feed Generator</generator><pubDate>Tue, 24 Nov 2009 18:24:34 CST</pubDate><item><guid isPermaLink="true">http://www.newser.com/story/20422/feds-ok-wyeths-new-antidepressant.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Feds OK Wyeth's New Antidepressant</title><description>Antidepressant Effexor XR will soon lose patent protection, and maker Wyeth is hoping Pristiq, the successor drug approved today by the FDA, will soften the financial blow. Higher-ups at the company gush over Pristiq's advantages, including zero acclimation time and no liver interaction, and hope that sales will offset losses...</description><link>http://www.newser.com/story/20422/feds-ok-wyeths-new-antidepressant.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Fri, 29 Feb 2008 19:41:17 CST</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/19599/prices-jump-for-top-drugs.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Prices Jump for Top Drugs</title><description>Drug companies have slapped a series of huge price hikes on some prescription drugs ahead of drug patent expirations, the Wall Street Journal reports. GlaxoSmithKline has raised the price of antidepressant Wellbutrin 44.5%, while Sanofi-Aventis hiked Ambien's price 70%. Wholesale prices for the top 50 drugs increased an average...</description><link>http://www.newser.com/story/19599/prices-jump-for-top-drugs.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Thu, 21 Feb 2008 4:45:00 CST</pubDate></item></channel></rss>